Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 12/2012

01-12-2012 | Review Article

Giant cell tumour of bone: a new evaluating system is necessary

Authors: Han Wang, Ningjun Wan, Yongcheng Hu

Published in: International Orthopaedics | Issue 12/2012

Login to get access

Abstract

Giant cell tumour (GCT) of bone is still one of the most obscure and intensively studied tumours of bone. The histogenesis of GCT remains unclear. The recommended therapy of GCT evolved during the 20th century. The best treatment should ensure local control and maintain function. Curettage has been the preferred treatment for most GCTs. Good results have also been published on the use of high-speed burr and local adjuvants. Local tumour control can be satisfactorily achieved by wide excision. However, treatment options for GCT have remained fairly static over the past 30 years and there is no widely held consensus regarding the standard treatment selection for all patients. This challenge may result from the fact that there are no single clinical, radiographic, histological or morphological aspects that allow surgeons to accurately predict the trend of a single lesion to recur. In this research, a comprehensive review of the previously described radiographic staging systems by Enneking and Campanacci et al. and the shortfalls associated with them are provided, and then the possible risk factors of predicting local recurrence or evaluating functional outcome of GCT are also discussed. A new preoperative evaluating system of GCT may be necessary and feasible, so that surgeons may accurately assess the aggressiveness or severity of GCT in order to reliably guide treatment decisions and predict outcomes.
Literature
1.
Fletcher CDM, Unni KK, Mertens F (2002) Pathology and genetics of tumours of soft tissue and bone. International Agency for Research on Cancer Press, Lyon, pp 309–313
2.
Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W (2012) Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am 94(5):461–467PubMedCrossRef
3.
Jeys LM, Suneja R, Chami G, Grimer RJ, Carter SR, Tillman RM (2006) Impending fractures in giant cell tumours of the distal femur: incidence and outcome. Int Orthop 30:135–138PubMedCrossRef
4.
Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G (2008) Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 79(1):86–93PubMedCrossRef
5.
Rooney RJ, Asirvatham R, Lifeso RM, Ali MA, Parikh S (1993) Giant cell tumour of bone. A surgical approach to grade III tumours. Int Orthop 17(2):87–92PubMedCrossRef
6.
Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM (1982) Giant cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am 64:755–761PubMed
7.
Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M (2010) Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev 36(1):1–7PubMedCrossRef
8.
Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ (2005) Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res 435:211–218PubMedCrossRef
9.
Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM, Canadian Sarcoma Group (2002) Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 397:248–258PubMedCrossRef
10.
Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ (2005) Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res 438:123–127PubMedCrossRef
11.
Mendenhall WM, Zlotecki RA, Scarborough MT, Gibbs CP, Mendenhall NP (2006) Giant cell tumor of bone. Am J Clin Oncol 29(1):96–99PubMedCrossRef
12.
13.
Szendröi M (2004) Giant-cell tumour of bone. J Bone Joint Surg Br 86(1):5–12PubMed
14.
Algawahmed H, Turcotte R, Farrokhyar F, Ghert M (2010) High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma 2010
15.
Shih HN, Hsu RW, Sim FH (1998) Excision curettage and allografting of giant cell tumours. World J Surg 22:432–437PubMedCrossRef
16.
Trieb K, Bitzan P, Dominkus M, Kotz R (2000) Giant-cell tumors of long bone. J Bone Joint Surg 82A:1360–1361
17.
Karpik M (2010) Giant cell tumor (tumor gigantocellularis, osteoclastoma)—epidemiology, diagnosis, treatment. Ortop Traumatol Rehabil 12(3):207–215PubMed
18.
Yu XC, Xu M, Song RX, Fu ZH, Liu XP (2010) Long-term outcome of giant cell tumors of bone around the knee treated by en bloc resection of tumor and reconstruction with prosthesis. Orthop Surg 2(3):211–217PubMedCrossRef
19.
Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS (1999) Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 81-A:811–820
20.
Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donnell RJ (2006) Local control of long bone giant cell tumor using curettage, burring and bone grafting without adjuvant therapy. Int Orthop 30:495–498PubMedCrossRef
21.
Labs K, Perka C, Schmidt GR (2001) Treatment of stages 2 and 3 giant-cell tumor. Arch Orthop Traum Surg 121:83–86CrossRef
22.
O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ (1994) Recurrence of giant-cell tumors of long bones after curettage and packing with cement. J Bone Joint Surg Am 76-A:1827–1833
23.
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 469(2):591–599PubMedCrossRef
24.
Masui F, Ushigome S, Fujii K (1998) Giant cell tumor of bone: a clinicopathological study of prognostic factors. Pathol Int 48:723–729PubMedCrossRef
25.
Puthoor DK, Puthezhath K (2012) Management of giant cell tumor of bone: computerized tomography based selection strategy and approaching the lesion through the site of cortical break. Orthop Surg 4(2):76–82PubMedCrossRef
26.
Gitelis S, Mallin BA, Piasecki P, Turner F (1993) Intralesional excision compared with en bloc resection for giant-cell tumors of bone. J Bone Joint Surg Am 75:1648–1655PubMed
27.
Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jörgensen P, Follerås G, Rydholm A, Scandinavian Sarcoma Group (2006) Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br 88:531–535PubMedCrossRef
28.
Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM, Canadian Sarcoma Group (2002) Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res (397):248–258
29.
McDonald DJ, Weber KL (2007) Giant cell tumor of bone. In: Schwartz HS (ed) Musculoskeletal tumors, 2nd edn. American Academy of Orthopaedic Surgeons, Rosemont, IL, pp 133–140
30.
Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134(9):969–978PubMedCrossRef
31.
Werner M (2006) Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 30(6):484–489PubMedCrossRef
32.
Jaffe HL, Lichtenstein L, Portis RB (1940) Giant cell tumor of bone: its pathological appearance, grading, supposed variants and treatment. Arch Pathol 30:993–1031
33.
Sanerkin NG (1980) Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 46:1641–1649PubMedCrossRef
34.
Lausten GS, Jensen PK, Schiødt T, Lund B (1996) Local recurrences in giant cell tumour of bone. Long-term follow up of 31 cases. Int Orthop 20(3):172–176PubMedCrossRef
35.
Larsson SE, Lorentzon R, Boquist L (1975) Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Joint Surg Am 57(2):167–173PubMed
36.
Dahlin DC (1985) Giant cell tumor of bone: highlights of 407 cases. Am J Roentgenol 144:955–960
37.
Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 9–24
38.
Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69(1):106–114PubMed
39.
Rock M (1990) Curettage of giant cell tumor of bone: Factors influencing local recurrences and metastasis. Chir Organi Mov 75(Suppl1):204–205PubMed
40.
Wuismann P, Härle A, Nommensen B (1989) Giant-cell tumour of bone: an analysis of 69 cases. Z Orthop 127:392–395CrossRef
41.
Szendroi M, Kiss J, Antal I (2003) Surgical treatment and prognostic factors in giant-cell tumor of bone. Acta Chir Orthop Traumatol Cech 70(3):142–150PubMed
42.
43.
Ward WG Sr, Gird L (2002) Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res 397:259–270PubMedCrossRef
44.
Lackman RD, Crawford EA, King JJ, Ogilvie CM (2009) Conservative treatment of Campanacci grade III proximal humerus giant cell tumors. Clin Orthop Relat Res 467(5):1355–1359PubMedCrossRef
45.
Deheshi BM, Jaffer SN, Griffin AM, Ferguson PC, Bell RS, Wunder JS (2007) Joint salvage for pathological fracture of giant cell tumor of the lower extremity. Clin Orthop Relat Res 459:96–104PubMedCrossRef
46.
Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF (2008) Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case–control study. Bone 42:68–73PubMedCrossRef
47.
Weber KL, Peabody T, Frassica FJ, Mott MP, Parsons TW (2010) Tumors for the general orthopedist: how to save your patients and practice. Instr Course Lect 59:579–591PubMed
48.
Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR (2009) Bone defects following curettage do not necessarily need augmentation. A retrospective study of 146 patients. Acta Orthop 80(1):4–8PubMedCrossRef
49.
Miszczyk L, Wydmanski J, Spindel J (2001) Efficacy of radiotherapy for giant cell tumor of bone: given either postoperatively or as sole treatment. Int J Radiat Oncol Biol Phys 49:1239–1242PubMedCrossRef
50.
Knochentumouren A, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU (2008) Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 90:1060–1067CrossRef
51.
Lewis VO, Wei A, Mendoza T, Primus F, Peabody T, Simon MA (2007) Argon beam coagulation as an adjuvant for local control of giant cell tumor. Clin Orthop Relat Res 454:192–197PubMedCrossRef
52.
Dreinhöfer KE, Rydholm A, Bauer HC, Kreicbergs A (1995) Giant-cell tumours with fracture at diagnosis: curettage and acrylic cementing in ten cases. J Bone Joint Surg Br 77(2):189–193PubMed
53.
Chen TH, Su YP, Chen WM (2005) Giant cell tumors of the knee: subchondral bone integrity affects the outcome. Int Orthop 29(1):30–34PubMedCrossRef
Metadata
Title
Giant cell tumour of bone: a new evaluating system is necessary
Authors
Han Wang
Ningjun Wan
Yongcheng Hu
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 12/2012
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-012-1664-9

Other articles of this Issue 12/2012

International Orthopaedics 12/2012 Go to the issue

Original Paper

Anterolateral approach using tibial tubercle osteotomy for total knee arthroplasty: can we predict failure?

Original Paper

Stress fractures in elderly patients

Original Paper

Obese patients may have more soft tissue impingement following primary total hip arthroplasty

Original Paper

The effects of autologous bone marrow mesenchymal stem cell arterial perfusion on vascular repair and angiogenesis in osteonecrosis of the femoral head in dogs

Original Paper

Arthrodesis of the talonavicular joint using angle-stable mini-plates: a prospective study

Original Paper

Shape of growth plate of proximal femur in children and its significance in the aetiology of slipped capital femoral epiphysis